nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmedetomidine—General Anesthesia—Propofol—epilepsy syndrome	0.54	1	CiPCiCtD
Dexmedetomidine—ADRA2A—epilepsy syndrome	0.0941	0.651	CbGaD
Dexmedetomidine—CYP2D6—epilepsy syndrome	0.0505	0.349	CbGaD
Dexmedetomidine—CYP2E1—Trimethadione—epilepsy syndrome	0.0184	0.107	CbGbCtD
Dexmedetomidine—CYP2E1—Felbamate—epilepsy syndrome	0.0184	0.107	CbGbCtD
Dexmedetomidine—CYP2E1—Clonazepam—epilepsy syndrome	0.0156	0.0913	CbGbCtD
Dexmedetomidine—CYP1A1—Propofol—epilepsy syndrome	0.0135	0.0785	CbGbCtD
Dexmedetomidine—CYP1A1—Phenobarbital—epilepsy syndrome	0.0129	0.075	CbGbCtD
Dexmedetomidine—CYP2E1—Rufinamide—epilepsy syndrome	0.0127	0.0744	CbGbCtD
Dexmedetomidine—CYP2E1—Propofol—epilepsy syndrome	0.0104	0.0606	CbGbCtD
Dexmedetomidine—CYP2E1—Phenobarbital—epilepsy syndrome	0.00993	0.058	CbGbCtD
Dexmedetomidine—CYP2E1—Midazolam—epilepsy syndrome	0.00979	0.0572	CbGbCtD
Dexmedetomidine—CYP2E1—Diazepam—epilepsy syndrome	0.00942	0.0549	CbGbCtD
Dexmedetomidine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00719	0.0419	CbGbCtD
Dexmedetomidine—CYP1A2—Primidone—epilepsy syndrome	0.00671	0.0391	CbGbCtD
Dexmedetomidine—CYP1A2—Propofol—epilepsy syndrome	0.00601	0.0351	CbGbCtD
Dexmedetomidine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00574	0.0335	CbGbCtD
Dexmedetomidine—CYP1A2—Diazepam—epilepsy syndrome	0.00545	0.0318	CbGbCtD
Dexmedetomidine—CYP2D6—Propofol—epilepsy syndrome	0.00495	0.0289	CbGbCtD
Dexmedetomidine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00429	0.025	CbGbCtD
Dexmedetomidine—SLC6A2—locus ceruleus—epilepsy syndrome	0.00189	0.166	CbGeAlD
Dexmedetomidine—SLC6A2—autonomic nervous system—epilepsy syndrome	0.001	0.0881	CbGeAlD
Dexmedetomidine—SLC6A2—ganglion—epilepsy syndrome	0.000557	0.0489	CbGeAlD
Dexmedetomidine—ADRA1D—forebrain—epilepsy syndrome	0.000378	0.0332	CbGeAlD
Dexmedetomidine—ADRA1D—telencephalon—epilepsy syndrome	0.000348	0.0306	CbGeAlD
Dexmedetomidine—SLC6A2—brainstem—epilepsy syndrome	0.000242	0.0213	CbGeAlD
Dexmedetomidine—SLC6A2—forebrain—epilepsy syndrome	0.000233	0.0205	CbGeAlD
Dexmedetomidine—CYP2D6—hindbrain—epilepsy syndrome	0.000231	0.0203	CbGeAlD
Dexmedetomidine—ADRA1B—head—epilepsy syndrome	0.000221	0.0195	CbGeAlD
Dexmedetomidine—ADRA1D—head—epilepsy syndrome	0.000216	0.019	CbGeAlD
Dexmedetomidine—SLC6A2—telencephalon—epilepsy syndrome	0.000215	0.0189	CbGeAlD
Dexmedetomidine—ADRA1B—nervous system—epilepsy syndrome	0.00021	0.0184	CbGeAlD
Dexmedetomidine—ADRA1D—nervous system—epilepsy syndrome	0.000205	0.018	CbGeAlD
Dexmedetomidine—ADRA1B—central nervous system—epilepsy syndrome	0.000202	0.0178	CbGeAlD
Dexmedetomidine—ADRA1D—central nervous system—epilepsy syndrome	0.000198	0.0174	CbGeAlD
Dexmedetomidine—ADRA2C—telencephalon—epilepsy syndrome	0.00019	0.0167	CbGeAlD
Dexmedetomidine—SLC6A2—medulla oblongata—epilepsy syndrome	0.000169	0.0148	CbGeAlD
Dexmedetomidine—ADRA2A—forebrain—epilepsy syndrome	0.000165	0.0145	CbGeAlD
Dexmedetomidine—ADRA1B—brain—epilepsy syndrome	0.00016	0.0141	CbGeAlD
Dexmedetomidine—ADRA1D—brain—epilepsy syndrome	0.000157	0.0138	CbGeAlD
Dexmedetomidine—ADRA2A—telencephalon—epilepsy syndrome	0.000152	0.0133	CbGeAlD
Dexmedetomidine—ADRA2C—medulla oblongata—epilepsy syndrome	0.000149	0.0131	CbGeAlD
Dexmedetomidine—CYP2E1—telencephalon—epilepsy syndrome	0.000148	0.0131	CbGeAlD
Dexmedetomidine—ADRA2C—midbrain—epilepsy syndrome	0.000137	0.012	CbGeAlD
Dexmedetomidine—SLC6A2—head—epilepsy syndrome	0.000134	0.0118	CbGeAlD
Dexmedetomidine—ADRA2C—spinal cord—epilepsy syndrome	0.000133	0.0117	CbGeAlD
Dexmedetomidine—CYP2D6—brainstem—epilepsy syndrome	0.000132	0.0116	CbGeAlD
Dexmedetomidine—CYP2D6—forebrain—epilepsy syndrome	0.000128	0.0112	CbGeAlD
Dexmedetomidine—SLC6A2—nervous system—epilepsy syndrome	0.000127	0.0111	CbGeAlD
Dexmedetomidine—SLC6A2—central nervous system—epilepsy syndrome	0.000122	0.0107	CbGeAlD
Dexmedetomidine—ADRA2A—medulla oblongata—epilepsy syndrome	0.000119	0.0105	CbGeAlD
Dexmedetomidine—ADRA2C—head—epilepsy syndrome	0.000118	0.0104	CbGeAlD
Dexmedetomidine—CYP2D6—telencephalon—epilepsy syndrome	0.000118	0.0103	CbGeAlD
Dexmedetomidine—CYP2E1—medulla oblongata—epilepsy syndrome	0.000117	0.0103	CbGeAlD
Dexmedetomidine—ADRA2C—nervous system—epilepsy syndrome	0.000112	0.00987	CbGeAlD
Dexmedetomidine—ADRA2A—midbrain—epilepsy syndrome	0.000109	0.00958	CbGeAlD
Dexmedetomidine—ADRA2C—central nervous system—epilepsy syndrome	0.000108	0.00951	CbGeAlD
Dexmedetomidine—ADRA2A—spinal cord—epilepsy syndrome	0.000106	0.00935	CbGeAlD
Dexmedetomidine—ADRA2C—cerebellum—epilepsy syndrome	0.000106	0.00929	CbGeAlD
Dexmedetomidine—CYP2E1—spinal cord—epilepsy syndrome	0.000104	0.00915	CbGeAlD
Dexmedetomidine—CYP1A1—head—epilepsy syndrome	0.000101	0.00891	CbGeAlD
Dexmedetomidine—SLC6A2—brain—epilepsy syndrome	9.69e-05	0.00852	CbGeAlD
Dexmedetomidine—CYP1A1—nervous system—epilepsy syndrome	9.61e-05	0.00845	CbGeAlD
Dexmedetomidine—ADRA2A—head—epilepsy syndrome	9.45e-05	0.00831	CbGeAlD
Dexmedetomidine—CYP1A1—central nervous system—epilepsy syndrome	9.25e-05	0.00814	CbGeAlD
Dexmedetomidine—CYP2E1—head—epilepsy syndrome	9.25e-05	0.00813	CbGeAlD
Dexmedetomidine—ADRA2A—nervous system—epilepsy syndrome	8.96e-05	0.00788	CbGeAlD
Dexmedetomidine—CYP2E1—nervous system—epilepsy syndrome	8.77e-05	0.00771	CbGeAlD
Dexmedetomidine—ADRA2A—central nervous system—epilepsy syndrome	8.63e-05	0.00758	CbGeAlD
Dexmedetomidine—ADRA2C—brain—epilepsy syndrome	8.58e-05	0.00755	CbGeAlD
Dexmedetomidine—CYP2E1—central nervous system—epilepsy syndrome	8.44e-05	0.00742	CbGeAlD
Dexmedetomidine—ADRA2A—cerebellum—epilepsy syndrome	8.43e-05	0.00741	CbGeAlD
Dexmedetomidine—CYP2E1—cerebellum—epilepsy syndrome	8.25e-05	0.00725	CbGeAlD
Dexmedetomidine—CYP1A1—brain—epilepsy syndrome	7.35e-05	0.00646	CbGeAlD
Dexmedetomidine—CYP2D6—head—epilepsy syndrome	7.32e-05	0.00644	CbGeAlD
Dexmedetomidine—CYP2D6—nervous system—epilepsy syndrome	6.94e-05	0.0061	CbGeAlD
Dexmedetomidine—ADRA2A—brain—epilepsy syndrome	6.85e-05	0.00602	CbGeAlD
Dexmedetomidine—CYP2E1—brain—epilepsy syndrome	6.7e-05	0.00589	CbGeAlD
Dexmedetomidine—CYP2D6—central nervous system—epilepsy syndrome	6.68e-05	0.00588	CbGeAlD
Dexmedetomidine—CYP2D6—cerebellum—epilepsy syndrome	6.53e-05	0.00574	CbGeAlD
Dexmedetomidine—CYP2D6—brain—epilepsy syndrome	5.3e-05	0.00466	CbGeAlD
Dexmedetomidine—Body temperature increased—Zonisamide—epilepsy syndrome	3.26e-05	0.000361	CcSEcCtD
Dexmedetomidine—Agitation—Valproic Acid—epilepsy syndrome	3.26e-05	0.000361	CcSEcCtD
Dexmedetomidine—Visual impairment—Gabapentin—epilepsy syndrome	3.26e-05	0.00036	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	3.26e-05	0.00036	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Phenytoin—epilepsy syndrome	3.26e-05	0.00036	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Clonazepam—epilepsy syndrome	3.25e-05	0.00036	CcSEcCtD
Dexmedetomidine—Dyspnoea—Lamotrigine—epilepsy syndrome	3.25e-05	0.000359	CcSEcCtD
Dexmedetomidine—Somnolence—Lamotrigine—epilepsy syndrome	3.24e-05	0.000358	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	3.24e-05	0.000358	CcSEcCtD
Dexmedetomidine—Mental disorder—Pregabalin—epilepsy syndrome	3.23e-05	0.000357	CcSEcCtD
Dexmedetomidine—Constipation—Carbamazepine—epilepsy syndrome	3.23e-05	0.000357	CcSEcCtD
Dexmedetomidine—Pain—Carbamazepine—epilepsy syndrome	3.23e-05	0.000357	CcSEcCtD
Dexmedetomidine—Dizziness—Propofol—epilepsy syndrome	3.22e-05	0.000356	CcSEcCtD
Dexmedetomidine—Diarrhoea—Levetiracetam—epilepsy syndrome	3.22e-05	0.000356	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Oxcarbazepine—epilepsy syndrome	3.21e-05	0.000355	CcSEcCtD
Dexmedetomidine—Malnutrition—Pregabalin—epilepsy syndrome	3.21e-05	0.000355	CcSEcCtD
Dexmedetomidine—Hyperglycaemia—Topiramate—epilepsy syndrome	3.21e-05	0.000354	CcSEcCtD
Dexmedetomidine—Pneumonia—Topiramate—epilepsy syndrome	3.19e-05	0.000352	CcSEcCtD
Dexmedetomidine—Dizziness—Midazolam—epilepsy syndrome	3.15e-05	0.000348	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	3.15e-05	0.000348	CcSEcCtD
Dexmedetomidine—Abdominal pain—Clonazepam—epilepsy syndrome	3.15e-05	0.000348	CcSEcCtD
Dexmedetomidine—Body temperature increased—Clonazepam—epilepsy syndrome	3.15e-05	0.000348	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Gabapentin—epilepsy syndrome	3.14e-05	0.000347	CcSEcCtD
Dexmedetomidine—Body temperature increased—Phenytoin—epilepsy syndrome	3.12e-05	0.000345	CcSEcCtD
Dexmedetomidine—Pain—Lamotrigine—epilepsy syndrome	3.12e-05	0.000345	CcSEcCtD
Dexmedetomidine—Constipation—Lamotrigine—epilepsy syndrome	3.12e-05	0.000345	CcSEcCtD
Dexmedetomidine—Nausea—Acetazolamide—epilepsy syndrome	3.11e-05	0.000344	CcSEcCtD
Dexmedetomidine—Dizziness—Levetiracetam—epilepsy syndrome	3.11e-05	0.000344	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Carbamazepine—epilepsy syndrome	3.11e-05	0.000344	CcSEcCtD
Dexmedetomidine—Abdominal pain—Oxcarbazepine—epilepsy syndrome	3.11e-05	0.000343	CcSEcCtD
Dexmedetomidine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	3.11e-05	0.000343	CcSEcCtD
Dexmedetomidine—Diarrhoea—Fosphenytoin—epilepsy syndrome	3.11e-05	0.000343	CcSEcCtD
Dexmedetomidine—Neuropathy peripheral—Topiramate—epilepsy syndrome	3.11e-05	0.000343	CcSEcCtD
Dexmedetomidine—Vomiting—Propofol—epilepsy syndrome	3.1e-05	0.000342	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Carbamazepine—epilepsy syndrome	3.08e-05	0.000341	CcSEcCtD
Dexmedetomidine—Urinary tract infection—Topiramate—epilepsy syndrome	3.08e-05	0.00034	CcSEcCtD
Dexmedetomidine—Rash—Propofol—epilepsy syndrome	3.07e-05	0.000339	CcSEcCtD
Dexmedetomidine—Dermatitis—Propofol—epilepsy syndrome	3.07e-05	0.000339	CcSEcCtD
Dexmedetomidine—Hypertension—Valproic Acid—epilepsy syndrome	3.06e-05	0.000339	CcSEcCtD
Dexmedetomidine—Headache—Propofol—epilepsy syndrome	3.05e-05	0.000337	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Gabapentin—epilepsy syndrome	3.05e-05	0.000337	CcSEcCtD
Dexmedetomidine—Chills—Gabapentin—epilepsy syndrome	3.03e-05	0.000335	CcSEcCtD
Dexmedetomidine—Vomiting—Midazolam—epilepsy syndrome	3.03e-05	0.000335	CcSEcCtD
Dexmedetomidine—Diarrhoea—Vigabatrin—epilepsy syndrome	3.03e-05	0.000335	CcSEcCtD
Dexmedetomidine—Anxiety—Valproic Acid—epilepsy syndrome	3.01e-05	0.000333	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Lamotrigine—epilepsy syndrome	3e-05	0.000332	CcSEcCtD
Dexmedetomidine—Rash—Midazolam—epilepsy syndrome	3e-05	0.000332	CcSEcCtD
Dexmedetomidine—Dizziness—Fosphenytoin—epilepsy syndrome	3e-05	0.000332	CcSEcCtD
Dexmedetomidine—Dermatitis—Midazolam—epilepsy syndrome	3e-05	0.000332	CcSEcCtD
Dexmedetomidine—Vomiting—Levetiracetam—epilepsy syndrome	2.99e-05	0.000331	CcSEcCtD
Dexmedetomidine—Headache—Midazolam—epilepsy syndrome	2.98e-05	0.00033	CcSEcCtD
Dexmedetomidine—Body temperature increased—Carbamazepine—epilepsy syndrome	2.98e-05	0.00033	CcSEcCtD
Dexmedetomidine—Abdominal pain—Carbamazepine—epilepsy syndrome	2.98e-05	0.00033	CcSEcCtD
Dexmedetomidine—Diarrhoea—Diazepam—epilepsy syndrome	2.98e-05	0.00033	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Lamotrigine—epilepsy syndrome	2.98e-05	0.000329	CcSEcCtD
Dexmedetomidine—Rash—Levetiracetam—epilepsy syndrome	2.97e-05	0.000328	CcSEcCtD
Dexmedetomidine—Anaemia—Pregabalin—epilepsy syndrome	2.97e-05	0.000328	CcSEcCtD
Dexmedetomidine—Dermatitis—Levetiracetam—epilepsy syndrome	2.96e-05	0.000328	CcSEcCtD
Dexmedetomidine—Mental disorder—Gabapentin—epilepsy syndrome	2.96e-05	0.000327	CcSEcCtD
Dexmedetomidine—Dry mouth—Valproic Acid—epilepsy syndrome	2.96e-05	0.000327	CcSEcCtD
Dexmedetomidine—Agitation—Pregabalin—epilepsy syndrome	2.95e-05	0.000326	CcSEcCtD
Dexmedetomidine—Headache—Levetiracetam—epilepsy syndrome	2.95e-05	0.000326	CcSEcCtD
Dexmedetomidine—Malnutrition—Gabapentin—epilepsy syndrome	2.94e-05	0.000325	CcSEcCtD
Dexmedetomidine—Dizziness—Vigabatrin—epilepsy syndrome	2.93e-05	0.000323	CcSEcCtD
Dexmedetomidine—Confusional state—Valproic Acid—epilepsy syndrome	2.92e-05	0.000323	CcSEcCtD
Dexmedetomidine—Bradycardia—Topiramate—epilepsy syndrome	2.9e-05	0.00032	CcSEcCtD
Dexmedetomidine—Nausea—Propofol—epilepsy syndrome	2.89e-05	0.00032	CcSEcCtD
Dexmedetomidine—Vomiting—Fosphenytoin—epilepsy syndrome	2.89e-05	0.000319	CcSEcCtD
Dexmedetomidine—Diarrhoea—Felbamate—epilepsy syndrome	2.89e-05	0.000319	CcSEcCtD
Dexmedetomidine—Abdominal pain—Lamotrigine—epilepsy syndrome	2.88e-05	0.000319	CcSEcCtD
Dexmedetomidine—Body temperature increased—Lamotrigine—epilepsy syndrome	2.88e-05	0.000319	CcSEcCtD
Dexmedetomidine—Dizziness—Diazepam—epilepsy syndrome	2.88e-05	0.000318	CcSEcCtD
Dexmedetomidine—Infection—Valproic Acid—epilepsy syndrome	2.88e-05	0.000318	CcSEcCtD
Dexmedetomidine—Rash—Fosphenytoin—epilepsy syndrome	2.86e-05	0.000316	CcSEcCtD
Dexmedetomidine—Dermatitis—Fosphenytoin—epilepsy syndrome	2.86e-05	0.000316	CcSEcCtD
Dexmedetomidine—Haemoglobin—Topiramate—epilepsy syndrome	2.86e-05	0.000316	CcSEcCtD
Dexmedetomidine—Headache—Fosphenytoin—epilepsy syndrome	2.84e-05	0.000314	CcSEcCtD
Dexmedetomidine—Haemorrhage—Topiramate—epilepsy syndrome	2.84e-05	0.000314	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.84e-05	0.000314	CcSEcCtD
Dexmedetomidine—Nausea—Midazolam—epilepsy syndrome	2.83e-05	0.000313	CcSEcCtD
Dexmedetomidine—Hallucination—Topiramate—epilepsy syndrome	2.83e-05	0.000313	CcSEcCtD
Dexmedetomidine—Tachycardia—Valproic Acid—epilepsy syndrome	2.83e-05	0.000313	CcSEcCtD
Dexmedetomidine—Diarrhoea—Zonisamide—epilepsy syndrome	2.82e-05	0.000312	CcSEcCtD
Dexmedetomidine—Vomiting—Vigabatrin—epilepsy syndrome	2.81e-05	0.000311	CcSEcCtD
Dexmedetomidine—Oedema peripheral—Topiramate—epilepsy syndrome	2.8e-05	0.00031	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.8e-05	0.00031	CcSEcCtD
Dexmedetomidine—Nausea—Levetiracetam—epilepsy syndrome	2.79e-05	0.000309	CcSEcCtD
Dexmedetomidine—Rash—Vigabatrin—epilepsy syndrome	2.79e-05	0.000308	CcSEcCtD
Dexmedetomidine—Dizziness—Felbamate—epilepsy syndrome	2.79e-05	0.000308	CcSEcCtD
Dexmedetomidine—Dermatitis—Vigabatrin—epilepsy syndrome	2.79e-05	0.000308	CcSEcCtD
Dexmedetomidine—Convulsion—Pregabalin—epilepsy syndrome	2.78e-05	0.000307	CcSEcCtD
Dexmedetomidine—Headache—Vigabatrin—epilepsy syndrome	2.77e-05	0.000306	CcSEcCtD
Dexmedetomidine—Hypertension—Pregabalin—epilepsy syndrome	2.77e-05	0.000306	CcSEcCtD
Dexmedetomidine—Vomiting—Diazepam—epilepsy syndrome	2.77e-05	0.000306	CcSEcCtD
Dexmedetomidine—Rash—Diazepam—epilepsy syndrome	2.75e-05	0.000304	CcSEcCtD
Dexmedetomidine—Dermatitis—Diazepam—epilepsy syndrome	2.75e-05	0.000303	CcSEcCtD
Dexmedetomidine—Visual impairment—Topiramate—epilepsy syndrome	2.74e-05	0.000303	CcSEcCtD
Dexmedetomidine—Dizziness—Zonisamide—epilepsy syndrome	2.73e-05	0.000302	CcSEcCtD
Dexmedetomidine—Headache—Diazepam—epilepsy syndrome	2.73e-05	0.000302	CcSEcCtD
Dexmedetomidine—Anxiety—Pregabalin—epilepsy syndrome	2.72e-05	0.000301	CcSEcCtD
Dexmedetomidine—Diarrhoea—Clonazepam—epilepsy syndrome	2.72e-05	0.000301	CcSEcCtD
Dexmedetomidine—Anaemia—Gabapentin—epilepsy syndrome	2.72e-05	0.000301	CcSEcCtD
Dexmedetomidine—Hypotension—Valproic Acid—epilepsy syndrome	2.71e-05	0.000299	CcSEcCtD
Dexmedetomidine—Agitation—Gabapentin—epilepsy syndrome	2.7e-05	0.000299	CcSEcCtD
Dexmedetomidine—Diarrhoea—Phenytoin—epilepsy syndrome	2.7e-05	0.000299	CcSEcCtD
Dexmedetomidine—Nausea—Fosphenytoin—epilepsy syndrome	2.7e-05	0.000298	CcSEcCtD
Dexmedetomidine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.69e-05	0.000297	CcSEcCtD
Dexmedetomidine—Vomiting—Felbamate—epilepsy syndrome	2.68e-05	0.000296	CcSEcCtD
Dexmedetomidine—Dry mouth—Pregabalin—epilepsy syndrome	2.67e-05	0.000295	CcSEcCtD
Dexmedetomidine—Rash—Felbamate—epilepsy syndrome	2.66e-05	0.000294	CcSEcCtD
Dexmedetomidine—Dermatitis—Felbamate—epilepsy syndrome	2.66e-05	0.000294	CcSEcCtD
Dexmedetomidine—Headache—Felbamate—epilepsy syndrome	2.64e-05	0.000292	CcSEcCtD
Dexmedetomidine—Confusional state—Pregabalin—epilepsy syndrome	2.64e-05	0.000292	CcSEcCtD
Dexmedetomidine—Cardiac disorder—Topiramate—epilepsy syndrome	2.64e-05	0.000292	CcSEcCtD
Dexmedetomidine—Dizziness—Clonazepam—epilepsy syndrome	2.63e-05	0.000291	CcSEcCtD
Dexmedetomidine—Nausea—Vigabatrin—epilepsy syndrome	2.63e-05	0.000291	CcSEcCtD
Dexmedetomidine—Vomiting—Zonisamide—epilepsy syndrome	2.62e-05	0.00029	CcSEcCtD
Dexmedetomidine—Dizziness—Phenytoin—epilepsy syndrome	2.61e-05	0.000289	CcSEcCtD
Dexmedetomidine—Rash—Zonisamide—epilepsy syndrome	2.6e-05	0.000288	CcSEcCtD
Dexmedetomidine—Infection—Pregabalin—epilepsy syndrome	2.6e-05	0.000288	CcSEcCtD
Dexmedetomidine—Dermatitis—Zonisamide—epilepsy syndrome	2.6e-05	0.000287	CcSEcCtD
Dexmedetomidine—Dizziness—Oxcarbazepine—epilepsy syndrome	2.6e-05	0.000287	CcSEcCtD
Dexmedetomidine—Nausea—Diazepam—epilepsy syndrome	2.59e-05	0.000286	CcSEcCtD
Dexmedetomidine—Headache—Zonisamide—epilepsy syndrome	2.59e-05	0.000286	CcSEcCtD
Dexmedetomidine—Dyspnoea—Valproic Acid—epilepsy syndrome	2.58e-05	0.000285	CcSEcCtD
Dexmedetomidine—Diarrhoea—Carbamazepine—epilepsy syndrome	2.58e-05	0.000285	CcSEcCtD
Dexmedetomidine—Angiopathy—Topiramate—epilepsy syndrome	2.58e-05	0.000285	CcSEcCtD
Dexmedetomidine—Somnolence—Valproic Acid—epilepsy syndrome	2.58e-05	0.000285	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.56e-05	0.000283	CcSEcCtD
Dexmedetomidine—Mediastinal disorder—Topiramate—epilepsy syndrome	2.56e-05	0.000283	CcSEcCtD
Dexmedetomidine—Tachycardia—Pregabalin—epilepsy syndrome	2.56e-05	0.000283	CcSEcCtD
Dexmedetomidine—Chills—Topiramate—epilepsy syndrome	2.55e-05	0.000282	CcSEcCtD
Dexmedetomidine—Convulsion—Gabapentin—epilepsy syndrome	2.55e-05	0.000282	CcSEcCtD
Dexmedetomidine—Hypertension—Gabapentin—epilepsy syndrome	2.54e-05	0.000281	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.53e-05	0.00028	CcSEcCtD
Dexmedetomidine—Vomiting—Clonazepam—epilepsy syndrome	2.53e-05	0.00028	CcSEcCtD
Dexmedetomidine—Vomiting—Phenytoin—epilepsy syndrome	2.51e-05	0.000278	CcSEcCtD
Dexmedetomidine—Rash—Clonazepam—epilepsy syndrome	2.51e-05	0.000277	CcSEcCtD
Dexmedetomidine—Dermatitis—Clonazepam—epilepsy syndrome	2.51e-05	0.000277	CcSEcCtD
Dexmedetomidine—Nausea—Felbamate—epilepsy syndrome	2.51e-05	0.000277	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	2.5e-05	0.000276	CcSEcCtD
Dexmedetomidine—Vomiting—Oxcarbazepine—epilepsy syndrome	2.5e-05	0.000276	CcSEcCtD
Dexmedetomidine—Anxiety—Gabapentin—epilepsy syndrome	2.5e-05	0.000276	CcSEcCtD
Dexmedetomidine—Dizziness—Carbamazepine—epilepsy syndrome	2.49e-05	0.000276	CcSEcCtD
Dexmedetomidine—Diarrhoea—Lamotrigine—epilepsy syndrome	2.49e-05	0.000276	CcSEcCtD
Dexmedetomidine—Headache—Clonazepam—epilepsy syndrome	2.49e-05	0.000275	CcSEcCtD
Dexmedetomidine—Rash—Phenytoin—epilepsy syndrome	2.49e-05	0.000275	CcSEcCtD
Dexmedetomidine—Mental disorder—Topiramate—epilepsy syndrome	2.49e-05	0.000275	CcSEcCtD
Dexmedetomidine—Dermatitis—Phenytoin—epilepsy syndrome	2.49e-05	0.000275	CcSEcCtD
Dexmedetomidine—Rash—Oxcarbazepine—epilepsy syndrome	2.48e-05	0.000274	CcSEcCtD
Dexmedetomidine—Constipation—Valproic Acid—epilepsy syndrome	2.48e-05	0.000274	CcSEcCtD
Dexmedetomidine—Pain—Valproic Acid—epilepsy syndrome	2.48e-05	0.000274	CcSEcCtD
Dexmedetomidine—Dermatitis—Oxcarbazepine—epilepsy syndrome	2.48e-05	0.000274	CcSEcCtD
Dexmedetomidine—Headache—Phenytoin—epilepsy syndrome	2.48e-05	0.000274	CcSEcCtD
Dexmedetomidine—Malnutrition—Topiramate—epilepsy syndrome	2.48e-05	0.000274	CcSEcCtD
Dexmedetomidine—Headache—Oxcarbazepine—epilepsy syndrome	2.46e-05	0.000272	CcSEcCtD
Dexmedetomidine—Nausea—Zonisamide—epilepsy syndrome	2.45e-05	0.000271	CcSEcCtD
Dexmedetomidine—Dry mouth—Gabapentin—epilepsy syndrome	2.45e-05	0.000271	CcSEcCtD
Dexmedetomidine—Hypotension—Pregabalin—epilepsy syndrome	2.45e-05	0.00027	CcSEcCtD
Dexmedetomidine—Confusional state—Gabapentin—epilepsy syndrome	2.42e-05	0.000268	CcSEcCtD
Dexmedetomidine—Dizziness—Lamotrigine—epilepsy syndrome	2.41e-05	0.000266	CcSEcCtD
Dexmedetomidine—Vomiting—Carbamazepine—epilepsy syndrome	2.4e-05	0.000265	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Valproic Acid—epilepsy syndrome	2.39e-05	0.000264	CcSEcCtD
Dexmedetomidine—Infection—Gabapentin—epilepsy syndrome	2.39e-05	0.000264	CcSEcCtD
Dexmedetomidine—Rash—Carbamazepine—epilepsy syndrome	2.38e-05	0.000263	CcSEcCtD
Dexmedetomidine—Dermatitis—Carbamazepine—epilepsy syndrome	2.38e-05	0.000263	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	2.37e-05	0.000262	CcSEcCtD
Dexmedetomidine—Nausea—Clonazepam—epilepsy syndrome	2.36e-05	0.000261	CcSEcCtD
Dexmedetomidine—Headache—Carbamazepine—epilepsy syndrome	2.36e-05	0.000261	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Gabapentin—epilepsy syndrome	2.35e-05	0.00026	CcSEcCtD
Dexmedetomidine—Nausea—Phenytoin—epilepsy syndrome	2.35e-05	0.000259	CcSEcCtD
Dexmedetomidine—Tachycardia—Gabapentin—epilepsy syndrome	2.34e-05	0.000259	CcSEcCtD
Dexmedetomidine—Dyspnoea—Pregabalin—epilepsy syndrome	2.34e-05	0.000258	CcSEcCtD
Dexmedetomidine—Nausea—Oxcarbazepine—epilepsy syndrome	2.34e-05	0.000258	CcSEcCtD
Dexmedetomidine—Somnolence—Pregabalin—epilepsy syndrome	2.33e-05	0.000257	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Gabapentin—epilepsy syndrome	2.32e-05	0.000257	CcSEcCtD
Dexmedetomidine—Vomiting—Lamotrigine—epilepsy syndrome	2.32e-05	0.000256	CcSEcCtD
Dexmedetomidine—Rash—Lamotrigine—epilepsy syndrome	2.3e-05	0.000254	CcSEcCtD
Dexmedetomidine—Dermatitis—Lamotrigine—epilepsy syndrome	2.3e-05	0.000254	CcSEcCtD
Dexmedetomidine—Abdominal pain—Valproic Acid—epilepsy syndrome	2.29e-05	0.000253	CcSEcCtD
Dexmedetomidine—Body temperature increased—Valproic Acid—epilepsy syndrome	2.29e-05	0.000253	CcSEcCtD
Dexmedetomidine—Anaemia—Topiramate—epilepsy syndrome	2.29e-05	0.000253	CcSEcCtD
Dexmedetomidine—Headache—Lamotrigine—epilepsy syndrome	2.28e-05	0.000252	CcSEcCtD
Dexmedetomidine—Agitation—Topiramate—epilepsy syndrome	2.28e-05	0.000251	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.26e-05	0.00025	CcSEcCtD
Dexmedetomidine—Hypotension—Gabapentin—epilepsy syndrome	2.24e-05	0.000248	CcSEcCtD
Dexmedetomidine—Nausea—Carbamazepine—epilepsy syndrome	2.24e-05	0.000248	CcSEcCtD
Dexmedetomidine—Constipation—Pregabalin—epilepsy syndrome	2.24e-05	0.000248	CcSEcCtD
Dexmedetomidine—Pain—Pregabalin—epilepsy syndrome	2.24e-05	0.000248	CcSEcCtD
Dexmedetomidine—Nausea—Lamotrigine—epilepsy syndrome	2.17e-05	0.000239	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.16e-05	0.000239	CcSEcCtD
Dexmedetomidine—Convulsion—Topiramate—epilepsy syndrome	2.15e-05	0.000237	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	2.14e-05	0.000237	CcSEcCtD
Dexmedetomidine—Dyspnoea—Gabapentin—epilepsy syndrome	2.14e-05	0.000237	CcSEcCtD
Dexmedetomidine—Hypertension—Topiramate—epilepsy syndrome	2.14e-05	0.000236	CcSEcCtD
Dexmedetomidine—Somnolence—Gabapentin—epilepsy syndrome	2.14e-05	0.000236	CcSEcCtD
Dexmedetomidine—Anxiety—Topiramate—epilepsy syndrome	2.1e-05	0.000232	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.07e-05	0.000229	CcSEcCtD
Dexmedetomidine—Body temperature increased—Pregabalin—epilepsy syndrome	2.07e-05	0.000229	CcSEcCtD
Dexmedetomidine—Abdominal pain—Pregabalin—epilepsy syndrome	2.07e-05	0.000229	CcSEcCtD
Dexmedetomidine—Dry mouth—Topiramate—epilepsy syndrome	2.06e-05	0.000228	CcSEcCtD
Dexmedetomidine—Pain—Gabapentin—epilepsy syndrome	2.05e-05	0.000227	CcSEcCtD
Dexmedetomidine—Constipation—Gabapentin—epilepsy syndrome	2.05e-05	0.000227	CcSEcCtD
Dexmedetomidine—Confusional state—Topiramate—epilepsy syndrome	2.04e-05	0.000225	CcSEcCtD
Dexmedetomidine—Infection—Topiramate—epilepsy syndrome	2.01e-05	0.000222	CcSEcCtD
Dexmedetomidine—Diarrhoea—Valproic Acid—epilepsy syndrome	1.98e-05	0.000219	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Gabapentin—epilepsy syndrome	1.98e-05	0.000219	CcSEcCtD
Dexmedetomidine—Thrombocytopenia—Topiramate—epilepsy syndrome	1.98e-05	0.000219	CcSEcCtD
Dexmedetomidine—Tachycardia—Topiramate—epilepsy syndrome	1.97e-05	0.000218	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.96e-05	0.000217	CcSEcCtD
Dexmedetomidine—Hyperhidrosis—Topiramate—epilepsy syndrome	1.95e-05	0.000216	CcSEcCtD
Dexmedetomidine—Dizziness—Valproic Acid—epilepsy syndrome	1.92e-05	0.000212	CcSEcCtD
Dexmedetomidine—Abdominal pain—Gabapentin—epilepsy syndrome	1.9e-05	0.00021	CcSEcCtD
Dexmedetomidine—Body temperature increased—Gabapentin—epilepsy syndrome	1.9e-05	0.00021	CcSEcCtD
Dexmedetomidine—Hypotension—Topiramate—epilepsy syndrome	1.89e-05	0.000209	CcSEcCtD
Dexmedetomidine—Vomiting—Valproic Acid—epilepsy syndrome	1.84e-05	0.000204	CcSEcCtD
Dexmedetomidine—Rash—Valproic Acid—epilepsy syndrome	1.83e-05	0.000202	CcSEcCtD
Dexmedetomidine—Dermatitis—Valproic Acid—epilepsy syndrome	1.83e-05	0.000202	CcSEcCtD
Dexmedetomidine—Headache—Valproic Acid—epilepsy syndrome	1.82e-05	0.000201	CcSEcCtD
Dexmedetomidine—Dyspnoea—Topiramate—epilepsy syndrome	1.8e-05	0.000199	CcSEcCtD
Dexmedetomidine—Somnolence—Topiramate—epilepsy syndrome	1.8e-05	0.000199	CcSEcCtD
Dexmedetomidine—Diarrhoea—Pregabalin—epilepsy syndrome	1.79e-05	0.000198	CcSEcCtD
Dexmedetomidine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.74e-05	0.000193	CcSEcCtD
Dexmedetomidine—Dizziness—Pregabalin—epilepsy syndrome	1.73e-05	0.000191	CcSEcCtD
Dexmedetomidine—Pain—Topiramate—epilepsy syndrome	1.73e-05	0.000191	CcSEcCtD
Dexmedetomidine—Constipation—Topiramate—epilepsy syndrome	1.73e-05	0.000191	CcSEcCtD
Dexmedetomidine—Nausea—Valproic Acid—epilepsy syndrome	1.72e-05	0.00019	CcSEcCtD
Dexmedetomidine—Vomiting—Pregabalin—epilepsy syndrome	1.67e-05	0.000184	CcSEcCtD
Dexmedetomidine—Feeling abnormal—Topiramate—epilepsy syndrome	1.67e-05	0.000184	CcSEcCtD
Dexmedetomidine—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.65e-05	0.000183	CcSEcCtD
Dexmedetomidine—Rash—Pregabalin—epilepsy syndrome	1.65e-05	0.000183	CcSEcCtD
Dexmedetomidine—Dermatitis—Pregabalin—epilepsy syndrome	1.65e-05	0.000182	CcSEcCtD
Dexmedetomidine—Diarrhoea—Gabapentin—epilepsy syndrome	1.64e-05	0.000182	CcSEcCtD
Dexmedetomidine—Headache—Pregabalin—epilepsy syndrome	1.64e-05	0.000181	CcSEcCtD
Dexmedetomidine—Body temperature increased—Topiramate—epilepsy syndrome	1.6e-05	0.000177	CcSEcCtD
Dexmedetomidine—Abdominal pain—Topiramate—epilepsy syndrome	1.6e-05	0.000177	CcSEcCtD
Dexmedetomidine—Dizziness—Gabapentin—epilepsy syndrome	1.59e-05	0.000176	CcSEcCtD
Dexmedetomidine—Nausea—Pregabalin—epilepsy syndrome	1.56e-05	0.000172	CcSEcCtD
Dexmedetomidine—Vomiting—Gabapentin—epilepsy syndrome	1.53e-05	0.000169	CcSEcCtD
Dexmedetomidine—Rash—Gabapentin—epilepsy syndrome	1.51e-05	0.000167	CcSEcCtD
Dexmedetomidine—Dermatitis—Gabapentin—epilepsy syndrome	1.51e-05	0.000167	CcSEcCtD
Dexmedetomidine—Headache—Gabapentin—epilepsy syndrome	1.5e-05	0.000166	CcSEcCtD
Dexmedetomidine—Nausea—Gabapentin—epilepsy syndrome	1.43e-05	0.000158	CcSEcCtD
Dexmedetomidine—Diarrhoea—Topiramate—epilepsy syndrome	1.38e-05	0.000153	CcSEcCtD
Dexmedetomidine—Dizziness—Topiramate—epilepsy syndrome	1.34e-05	0.000148	CcSEcCtD
Dexmedetomidine—Vomiting—Topiramate—epilepsy syndrome	1.28e-05	0.000142	CcSEcCtD
Dexmedetomidine—Rash—Topiramate—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Dexmedetomidine—Dermatitis—Topiramate—epilepsy syndrome	1.27e-05	0.000141	CcSEcCtD
Dexmedetomidine—Headache—Topiramate—epilepsy syndrome	1.27e-05	0.00014	CcSEcCtD
Dexmedetomidine—Nausea—Topiramate—epilepsy syndrome	1.2e-05	0.000133	CcSEcCtD
Dexmedetomidine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	2.25e-06	5.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	2.25e-06	5.36e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	2.23e-06	5.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—YWHAZ—epilepsy syndrome	2.2e-06	5.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—S100B—epilepsy syndrome	2.2e-06	5.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	2.19e-06	5.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—NGF—epilepsy syndrome	2.18e-06	5.19e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SOCS3—epilepsy syndrome	2.17e-06	5.19e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CDC42—epilepsy syndrome	2.17e-06	5.18e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—SLC2A1—epilepsy syndrome	2.17e-06	5.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—S100B—epilepsy syndrome	2.16e-06	5.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	2.16e-06	5.15e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	2.14e-06	5.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	2.14e-06	5.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PLCB1—epilepsy syndrome	2.14e-06	5.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SOCS3—epilepsy syndrome	2.14e-06	5.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—TH—epilepsy syndrome	2.13e-06	5.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CDC42—epilepsy syndrome	2.13e-06	5.09e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	2.13e-06	5.07e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCR5—epilepsy syndrome	2.12e-06	5.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	2.12e-06	5.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	2.12e-06	5.05e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	2.11e-06	5.04e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.11e-06	5.03e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.1e-06	5.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	2.1e-06	5.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AVP—epilepsy syndrome	2.1e-06	5.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.1e-06	5.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	2.08e-06	4.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	2.08e-06	4.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—HTR2A—epilepsy syndrome	2.07e-06	4.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	2.07e-06	4.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	2.07e-06	4.93e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AVP—epilepsy syndrome	2.07e-06	4.93e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	2.06e-06	4.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	2.06e-06	4.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	2.06e-06	4.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	2.06e-06	4.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—CAT—epilepsy syndrome	2.03e-06	4.85e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	2.03e-06	4.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	2.01e-06	4.8e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	2e-06	4.77e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	2e-06	4.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.99e-06	4.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HES1—epilepsy syndrome	1.99e-06	4.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—AGT—epilepsy syndrome	1.98e-06	4.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	1.98e-06	4.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—TSC2—epilepsy syndrome	1.97e-06	4.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	1.97e-06	4.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AGT—epilepsy syndrome	1.97e-06	4.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	1.96e-06	4.69e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	1.96e-06	4.67e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HES1—epilepsy syndrome	1.95e-06	4.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—APOE—epilepsy syndrome	1.94e-06	4.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—FYN—epilepsy syndrome	1.93e-06	4.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	1.93e-06	4.61e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—APOE—epilepsy syndrome	1.93e-06	4.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—H2AFX—epilepsy syndrome	1.92e-06	4.59e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MEF2C—epilepsy syndrome	1.92e-06	4.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	1.92e-06	4.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	1.91e-06	4.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—FYN—epilepsy syndrome	1.9e-06	4.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—H2AFX—epilepsy syndrome	1.89e-06	4.52e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MEF2C—epilepsy syndrome	1.89e-06	4.51e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—HMOX1—epilepsy syndrome	1.89e-06	4.51e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—KDR—epilepsy syndrome	1.89e-06	4.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	1.89e-06	4.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	1.88e-06	4.48e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	1.87e-06	4.46e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—CAT—epilepsy syndrome	1.86e-06	4.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—YWHAZ—epilepsy syndrome	1.86e-06	4.43e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	1.84e-06	4.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—NGF—epilepsy syndrome	1.84e-06	4.38e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—YWHAZ—epilepsy syndrome	1.83e-06	4.36e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—PRKCB—epilepsy syndrome	1.82e-06	4.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ABCB1—epilepsy syndrome	1.81e-06	4.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—IL6ST—epilepsy syndrome	1.81e-06	4.32e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—NGF—epilepsy syndrome	1.81e-06	4.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCR5—epilepsy syndrome	1.79e-06	4.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	1.78e-06	4.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—HMOX1—epilepsy syndrome	1.78e-06	4.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	1.78e-06	4.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	1.77e-06	4.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	1.77e-06	4.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	1.77e-06	4.21e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	1.76e-06	4.2e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—CAT—epilepsy syndrome	1.76e-06	4.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCR5—epilepsy syndrome	1.76e-06	4.19e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	1.75e-06	4.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—HTR2A—epilepsy syndrome	1.75e-06	4.17e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	1.74e-06	4.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—HTR2A—epilepsy syndrome	1.72e-06	4.1e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	1.72e-06	4.1e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ABCB1—epilepsy syndrome	1.71e-06	4.08e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.71e-06	4.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	1.71e-06	4.07e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	1.7e-06	4.07e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.7e-06	4.06e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.69e-06	4.04e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—GPX1—epilepsy syndrome	1.69e-06	4.02e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.68e-06	4.01e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—POMC—epilepsy syndrome	1.67e-06	3.98e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—TSC2—epilepsy syndrome	1.66e-06	3.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AGT—epilepsy syndrome	1.66e-06	3.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—POMC—epilepsy syndrome	1.65e-06	3.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Hemostasis—AKT1—epilepsy syndrome	1.65e-06	3.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	1.64e-06	3.91e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—TSC2—epilepsy syndrome	1.63e-06	3.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	1.63e-06	3.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AGT—epilepsy syndrome	1.63e-06	3.89e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.63e-06	3.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—APOE—epilepsy syndrome	1.62e-06	3.88e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CCL2—epilepsy syndrome	1.62e-06	3.86e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	1.61e-06	3.85e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.61e-06	3.85e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AGT—epilepsy syndrome	1.61e-06	3.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—TH—epilepsy syndrome	1.61e-06	3.83e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—APOE—epilepsy syndrome	1.6e-06	3.81e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—KDR—epilepsy syndrome	1.59e-06	3.8e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—GPX1—epilepsy syndrome	1.59e-06	3.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—APOE—epilepsy syndrome	1.58e-06	3.77e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	1.57e-06	3.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—KDR—epilepsy syndrome	1.57e-06	3.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	1.56e-06	3.73e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.56e-06	3.72e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.53e-06	3.66e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.53e-06	3.66e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.53e-06	3.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.53e-06	3.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—ALB—epilepsy syndrome	1.52e-06	3.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.51e-06	3.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—PRKCB—epilepsy syndrome	1.51e-06	3.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—IL6ST—epilepsy syndrome	1.5e-06	3.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	1.49e-06	3.56e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	1.49e-06	3.56e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AGT—epilepsy syndrome	1.48e-06	3.53e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—FGF2—epilepsy syndrome	1.46e-06	3.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	1.46e-06	3.49e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	1.45e-06	3.47e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	1.45e-06	3.46e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—APOE—epilepsy syndrome	1.45e-06	3.46e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	1.45e-06	3.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	1.42e-06	3.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—POMC—epilepsy syndrome	1.4e-06	3.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AGT—epilepsy syndrome	1.39e-06	3.33e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	1.38e-06	3.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—POMC—epilepsy syndrome	1.37e-06	3.28e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	1.37e-06	3.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—APOE—epilepsy syndrome	1.37e-06	3.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CCL2—epilepsy syndrome	1.37e-06	3.26e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—TH—epilepsy syndrome	1.36e-06	3.25e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—RELA—epilepsy syndrome	1.36e-06	3.24e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—POMC—epilepsy syndrome	1.36e-06	3.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	1.35e-06	3.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	1.35e-06	3.21e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CCL2—epilepsy syndrome	1.34e-06	3.21e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	1.34e-06	3.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	1.34e-06	3.2e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.34e-06	3.2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MTOR—epilepsy syndrome	1.33e-06	3.18e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—PTGS2—epilepsy syndrome	1.33e-06	3.18e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.32e-06	3.16e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	1.32e-06	3.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	1.32e-06	3.15e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	1.29e-06	3.08e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.29e-06	3.07e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—POMC—epilepsy syndrome	1.24e-06	2.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	1.24e-06	2.97e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	1.24e-06	2.96e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—GPCR downstream signaling—AKT1—epilepsy syndrome	1.24e-06	2.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—ALB—epilepsy syndrome	1.24e-06	2.95e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—FGF2—epilepsy syndrome	1.23e-06	2.94e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	1.23e-06	2.93e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—CASP3—epilepsy syndrome	1.22e-06	2.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—FGF2—epilepsy syndrome	1.21e-06	2.9e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	1.2e-06	2.87e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.2e-06	2.86e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—JUN—epilepsy syndrome	1.19e-06	2.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—POMC—epilepsy syndrome	1.17e-06	2.8e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—MMP9—epilepsy syndrome	1.16e-06	2.76e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—RELA—epilepsy syndrome	1.15e-06	2.73e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.14e-06	2.71e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—ALB—epilepsy syndrome	1.13e-06	2.71e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	1.13e-06	2.7e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—RELA—epilepsy syndrome	1.13e-06	2.69e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MTOR—epilepsy syndrome	1.12e-06	2.68e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling by GPCR—AKT1—epilepsy syndrome	1.12e-06	2.68e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.12e-06	2.67e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.12e-06	2.66e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	1.11e-06	2.65e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.11e-06	2.64e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MTOR—epilepsy syndrome	1.11e-06	2.64e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.09e-06	2.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	2.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.07e-06	2.56e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—ALB—epilepsy syndrome	1.07e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—SRC—epilepsy syndrome	1.07e-06	2.55e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.05e-06	2.5e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.05e-06	2.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—GPCR downstream signaling—AKT1—epilepsy syndrome	1.04e-06	2.49e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—VEGFA—epilepsy syndrome	1.04e-06	2.48e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—CASP3—epilepsy syndrome	1.03e-06	2.47e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.03e-06	2.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.03e-06	2.45e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—CASP3—epilepsy syndrome	1.02e-06	2.43e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.01e-06	2.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.01e-06	2.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—JUN—epilepsy syndrome	1e-06	2.39e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1e-06	2.39e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—PTGS2—epilepsy syndrome	9.93e-07	2.37e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—JUN—epilepsy syndrome	9.87e-07	2.36e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—MMP9—epilepsy syndrome	9.76e-07	2.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	9.63e-07	2.3e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—MMP9—epilepsy syndrome	9.61e-07	2.29e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling by GPCR—AKT1—epilepsy syndrome	9.47e-07	2.26e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	9.38e-07	2.24e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—PTGS2—epilepsy syndrome	9.36e-07	2.23e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling by GPCR—AKT1—epilepsy syndrome	9.32e-07	2.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	9.3e-07	2.22e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	9.12e-07	2.18e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—SRC—epilepsy syndrome	9e-07	2.15e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AGT—epilepsy syndrome	8.89e-07	2.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—SRC—epilepsy syndrome	8.86e-07	2.11e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—POMC—epilepsy syndrome	8.83e-07	2.11e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—VEGFA—epilepsy syndrome	8.77e-07	2.09e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—APOE—epilepsy syndrome	8.71e-07	2.08e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—VEGFA—epilepsy syndrome	8.63e-07	2.06e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	8.47e-07	2.02e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	8.39e-07	2e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	8.15e-07	1.95e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—ALB—epilepsy syndrome	8.05e-07	1.92e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	7.93e-07	1.89e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	7.69e-07	1.84e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—POMC—epilepsy syndrome	7.48e-07	1.79e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	7.31e-07	1.74e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	7.12e-07	1.7e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	7.04e-07	1.68e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—ALB—epilepsy syndrome	6.82e-07	1.63e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Metabolism—AKT1—epilepsy syndrome	6.69e-07	1.6e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1D—Signaling Pathways—AKT1—epilepsy syndrome	6.63e-07	1.58e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	5.99e-07	1.43e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	5.97e-07	1.42e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2C—Signaling Pathways—AKT1—epilepsy syndrome	5.59e-07	1.33e-05	CbGpPWpGaD
Dexmedetomidine—ADRA1B—Signaling Pathways—AKT1—epilepsy syndrome	5.5e-07	1.31e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	5.43e-07	1.3e-05	CbGpPWpGaD
Dexmedetomidine—CYP2E1—Metabolism—AKT1—epilepsy syndrome	4.99e-07	1.19e-05	CbGpPWpGaD
Dexmedetomidine—CYP1A1—Metabolism—AKT1—epilepsy syndrome	4.7e-07	1.12e-05	CbGpPWpGaD
Dexmedetomidine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	4.54e-07	1.08e-05	CbGpPWpGaD
Dexmedetomidine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	3.54e-07	8.45e-06	CbGpPWpGaD
Dexmedetomidine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	3e-07	7.16e-06	CbGpPWpGaD
